Infectious Disease Update - What’s New in ID?

McMaster University Department of Medicine

A. Kapoor

Updates in Fecal Microbiota Transplantation

UCSF School of Medicine

M. Brondfield

Proton Pump Inhibitors: Debunking Media Myths

Houston Methodist

C. Kim

A Clinician's Guide to the Basics of the Microbiota and FMT for Gast…

Paul Feuerstadt

Diagnosis and Treatment of Clostridioides difficile and Recurrent In…

ACG 2024 Conference Coverage

N. Stollman

Moderation of the Microbiome and C. difficile Infection: Have We Fin…

ACG 2023 Conference Coverage

P. Feuerstadt

Management of C. difficile Infections: GI Society Guidelines

Peggy Lillis Foundation

C. Kelly

Pediatric C. difficile Infection

Peggy Lillis Foundation

M. Nicholson

Novel Small Molecule Treatment for C. difficile Infection, REC-3964

Peggy Lillis Foundation

A. Skinner

Harnessing the Microbiome to Treat Gut Disease: Myth or Reality?

Keck School of Medicine of USC

B. Zhang

C. Difficile Colitis: Management in 2024

Stanford Medicine

K. Keyashian

AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies …

DDW 2024 Conference Coverage

C. Kelly

Two-Way Patient Management: ID and Primary Care

Baystate Health

C. Magauran

C. Difficile Infection and Inflammatory Bowel Disease

Maria Oliva-Hemker

Guideline Update: Fecal Microbiota Transplantation for Recurrent C. …

EBMed

P. Feuerstadt

When and What to Test for Diarrhea: Focus on Stool Testing

ACG 2024 Conference Coverage

M. Camilleri

Top Studies Influencing ID Practice in the Last Year

Baystate Health

U. Saha

IDWeek 2023 Insights: The Commercial Development of Human Derived In…

Insights from IDWeek 2023

M. Woodworth

IDSA/SHEA Guidelines for Antimicrobial Managment of C. difficile Inf…

Peggy Lillis Foundation

S. Johnson

Diagnosis of C. difficile Infection

Peggy Lillis Foundation

E. Dubberke